ENTX · Forms 3, 4, 5
Insider trades at Entera Bio Ltd.
No open-market insider buys or sells at Entera Bio Ltd. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Entera Bio Ltd. (ENTX) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Riccardo Paolo Camisasca | Chief Medical Officer | Became an insider (Form 3) | Form 3 | ||||
| Steven D Rubin | Director | Award | 19,117 | Form 4 | |||
| Yonatan Malca | Director | Award | 22,815 | Form 4 | |||
| Haya Taitel | Director | Award | 20,790 | Form 4 | |||
| Sean Ellis | Director | Award | 20,034 | Form 4 | |||
| Dana Yaacov-Garbeli | Chief Financial Officer | Options or other derivatives | Form 4 | ||||
| Hillel Galitzer | Chief Operating Officer | Options or other derivatives | Form 4 | ||||
| Gregory Burshtein | Chief of R&D | Options or other derivatives | Form 4 | ||||
| Miranda Jayne Toledano | Chief Executive Officer | Options or other derivatives | Form 4 | ||||
| Geno J Germano | Director | Award | 25,014 | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.